AexeRNA Therapeutics

Biotechnology company developing a next generation high-potency targetable mRNA LNP delivery platform technology.

Launch date

2020

Employees

Bethesda Maryland (HQ)

Date	Investors	Amount	Round
Nov 2023*	BioNTech	N/A	Acquisition
Total Funding		-

Recent News about AexeRNA Therapeutics